Guidelines and definitions for research on epithelial-mesenchymal transition
Open accessThe DOI matches its Crossref record; 138 of the 139 references it cites were found in a registry or an index.
Abstract
Epithelial–mesenchymal transition (EMT) encompasses dynamic changes in cellular organization from epithelial to mesenchymal phenotypes, which leads to functional changes in cell migration and invasion. EMT occurs in a diverse range of physiological and pathological conditions and is driven by a conserved set of inducing signals, transcriptional regulators and downstream effectors. With over 5,700 publications indexed by Web of Science in 2019 alone, research on EMT is expanding rapidly. This growing interest warrants the need for a consensus among researchers when referring to and undertaking research on EMT. This Consensus Statement, mediated by ‘the EMT International Association’ (TEMTIA), is the outcome of a 2-year-long discussion among EMT researchers and aims to both clarify the nomenclature and provide definitions and guidelines for EMT research in future publications. We trust that these guidelines will help to reduce misunderstanding and misinterpretation of research data generated in various experimental models and to promote cross-disciplinary collaboration to identify and address key open questions in this research field. While recognizing the importance of maintaining diversity in experimental approaches and conceptual frameworks, we emphasize that lasting contributions of EMT research to increasing our understanding of developmental processes and combatting cancer and other diseases depend on the adoption of a unified terminology to describe EMT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“consistent with enhanced paracrine signaling from increased numbers of senescent neighbors and with established features of epithelial aging.23,25,32–35”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Epithelial-to-mesenchymal transition (EMT) is another potential mechanism of both intrinsic and acquired resistance to KRASG12C inhibitors.”
From The current state of the art and future trends in RAS-targeted cancer therapies (2022) · cites this paper as [114]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Expression of canonical EMT transcription factors, including Snai1/2, Zeb1/2, and Twist1, is observed in both contexts77.”
From Cell diversity and plasticity during atrioventricular heart valve EMTs (2023) · cites this paper as [77]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A major challenge in the field has been to reliably identify senescent cells in tissues and organs.23,25,32–35”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Self-citationNew insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876
Self-citationTwist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Self-citationCano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Self-citationEmerging Biological Principles of Metastasis
Lambert, A. W., Pattabiraman, D. R., & Weinberg, R. A. (2017) · Cell · doi:10.1016/j.cell.2016.11.037 · Cited by 3,067
Self-citationBatlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., Isakoff, S. J., Ciciliano, J. C., Wells, M. N., Shah, A. M., et al. (2013) · Science · doi:10.1126/science.1228522 · Cited by 2,476
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Self-citationZheng, X., Carstens, J. L., Kim, J., Scheible, M., Kaye, J., Sugimoto, H., Wu, C.-C., LeBleu, V. S., & Kalluri, R. (2015) · Nature · doi:10.1038/nature16064 · Cited by 2,032
Self-citationFischer, K. R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S. T. C., Choi, H., El Rayes, T., Ryu, S., Troeger, J., et al. (2015) · Nature · doi:10.1038/nature15748 · Cited by 1,791
Research works printed but not linked: 1
- Hay, E. D. in Epithelial–Mesenchymal Interactions: 18th Hahnemann Symposium (eds R. Fleischmajer & Billingham, R. E.) 31–35 (Williams and Wilkins, 1968).
Cited by
Items 601–700 of 1,001
In Vitro Models of Ovarian Cancer: Bridging the Gap between Pathophysiology and Mechanistic Models
Lopez, E., Kamboj, S., Chen, C., Wang, Z., Kellouche, S., Leroy‐Dudal, J., Carreiras, F., Lambert, A., & Aimé, C. (2023) · Biomolecules · doi:10.3390/biom13010103 · Cited by 23
“Modeling and integrating key parameters of the cell microenvironment is a crucial step to foster progress in biological and biomedical research, and particularly here for investigating cell EMP, migration, and metastasis progression.”
BackgroundInfluentialGu, H., Shi, R., Chen, X., Lv, W., Hu, X., Xu, C., Pan, Y., He, X., Wu, A., & Li, J. (2023) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.3c00207 · Cited by 23
Cervantes‐Villagrana, R. D., García‐Jiménez, I., & Vázquez‐Prado, J. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110749 · Cited by 23
Cheraghi-shavi, T., Jalal, R., & Minuchehr, Z. (2023) · PLoS ONE · doi:10.1371/journal.pone.0289535 · Cited by 23
“EMT triggers several alterations in cellular physiology and morphology such as loss of cell polarity, cell–cell adhesion in epithelial cells, gain of motility and migratory properties, as well as degrading and reorganizing the extracellular matrix (ECM) in mesenchymal cells, leading to enhanced cancer invasion [22].”
BackgroundAdinolfi, E., Marchi, E. D., Grignolo, M., Szymczak, B., & Pegoraro, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813906 · Cited by 23
Ferreira, D., Santos‐Pereira, C., Costa, M. F., Afonso, J., Yang, S., Hensel, J., McAndrews, K. M., Longatto‐Filho, A., Fernandes, R., Melo, J. B., et al. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213643 · Cited by 23
Self-citationOshi, M., Roy, A. M., Li, Y., Kinoshita, S., Tamura, Y., Kosaka, T., Akiyama, H., Kunisaki, C., Takabe, K., & Endo, I. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00756-w · Cited by 23
The Role of Vimentin in Human Corneal Fibroblast Spreading and Myofibroblast Transformation
Miron-Mendoza, M., Poole, K., DiCesare, S., Nakahara, E., Bhatt, M. P., Hulleman, J. D., & Petroll, W. M. (2024) · Cells · doi:10.3390/cells13131094 · Cited by 23
“Figure S3.”
Farahzadi, R., Fathi, E., Vandghanooni, S., & Valipour, B. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189177 · Cited by 24
Verma, A., Patel, K., & Kumar, A. (2024) · Nanoscale Advances · doi:10.1039/d4na00660g · Cited by 23
Li, Q., Liu, Z., Ge, Y., Liu, X., Xie, X., Zheng, Z., Ma, Y., & Liu, B. (2020) · Oncology Reports · doi:10.3892/or.2020.7640 · Cited by 23
“Epithelial‐mesenchymal transition (EMT) is a cellular process during which epithelial cells acquire mesenchymal phenotypes and behavior following the downregulation of epithelial features (25).”
BackgroundAncel, J., Dewolf, M., Deslée, G., Nawrocki‐Raby, B., Dalstein, V., Gilles, C., & Polette, M. (2020) · Cells Tissues Organs · doi:10.1159/000510103 · Cited by 23
SOX factors as cell-state regulators in the mammary gland and breast cancer
Liu, Y., & Guo, W. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.01.002 · Cited by 23
Lin, L., Wen, J., Lin, B., Chen, H., Bhandari, A., Qi, Y., Zheng, D., & Wang, O. (2021) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmab016 · Cited by 23
Nuclear Syndecan-1 Regulates Epithelial-Mesenchymal Plasticity in Tumor Cells
Kumar-Singh, A., Parniewska, M. M., Γιωτοπούλου, Ν., Javadi, J., Sun, W., Szatmári, T., Dobra, K., Hjerpe, A., & Fuxe, J. (2021) · Biology · doi:10.3390/biology10060521 · Cited by 23
Self-citationTGFβ-induced expression of long noncoding lincRNA Platr18 controls breast cancer axonogenesis
Grelet, S., Fréreux, C., Obellianne, C., Noguchi, K., Howley, B. V., Dalton, A. C., & Howe, P. H. (2021) · Life Science Alliance · doi:10.26508/lsa.202101261 · Cited by 23
“Epithelial-mesenchymal transition (EMT) occurs normally during early embryonic development as well as later in development and during wound healing in adults and is also reactivated during cancer progression and metastasis (Tsai et al, 2012; Tran et al, 2014; Krebs et al, 2017; Yang et al, 2020).”
BackgroundYang, X., Chen, R., Chen, Y., Zhou, Y., Wu, C., Li, Q., Wu, J., Hu, W., Zhao, W., Wei, W., et al. (2022) · Cancer Science · doi:10.1111/cas.15299 · Cited by 23
Heterogeneity and dynamic of EMT through the plasticity of ribosome and mRNA translation
Morin, C., Moyret‐Lalle, C., Mertani, H. C., Diaz, J., & Marcel, V. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188718 · Cited by 23
The Role of Programmed Necrosis in Colorectal Cancer
Yu, Y., Gámez‐Belmonte, R., Patankar, J. V., Liebing, E., & Becker, C. (2022) · Cancers · doi:10.3390/cancers14174295 · Cited by 23
“Furthermore, epithelial-to-mesenchymal transition (EMT), a process believed to generate cancer stem cells and metastasis, sensitizes tumor cells to ferroptosis [45,46].”
BackgroundContribution of mechanical homeostasis to epithelial-mesenchymal transition
Han, S. J., Kwon, S., & Kim, K. S. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00720-6 · Cited by 23
Perez‐Mies, B., Caniego-Casas, T., Bardi, T., Carretero‐Barrio, I., Benito, A., García‐Cosío, M., González-García, I., Pizarro, D., Cancio-Suárez, M. R., Cristóbal, E., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.976759 · Cited by 23
“True EMT is a complex process that implies that epithelial cells lose their epithelial characteristics and acquire a mesenchymal phenotype (21).”
BackgroundZhang, J., van Dinther, M., Thorikay, M., Gourabi, B. M., Kruithof, B. P. T., & ten Dijke, P. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04672-w · Cited by 23
Wang, G., Wu, Y., Su, Y., Qu, N., Chen, B. Z., Zhou, D., Yuan, L., Yin, M., Liu, M., & Zhou, W. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05536-6 · Cited by 22
“…the TCF12/GRB7 axis for the treatment of HER2 + BC. EMT is a crucial biological phenomenon involved in embryonic development, exhibiting loss of cell polarity or intercellular adhesion by epithelial cells, which then acquire migratory and invasive features to become mesenchymal cells [54, 55].”
BackgroundEndothelial-to-mesenchymal transition in cardiovascular diseases
Zhang, Z., Fang, Z., Ge, J., & Li, H. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2025.05.002 · Cited by 22
Squiavinato, A. C. M. S., Vasconcelos, R. I., Gehren, A. S., Fernandes, P. V., de Oliveira, I. M., Boroni, M., & Morgado‐Díaz, J. A. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01770-w · Cited by 22
“EMT is a reversible cellular program in which epithelial cells transiently lose proteins of the junctional complex and acquire mesenchymal proteins which develop quasi-mesenchymal cell states, leading to more aggressive phenotypes [4, 5].”
BackgroundShi, H., & Yang, Y. (2021) · Cancer Medicine · doi:10.1002/cam4.3902 · Cited by 22
Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis
Tian, X., Wang, J., Jiang, L., Jiang, Y., Xu, J., & Feng, X. (2022) · Journal of Oncology · doi:10.1155/2022/2208176 · Cited by 22
“EMT is a cellular programme in which epithelial cells acquire mesenchymal phenotypes with a loss of epithelial phenotypes [2].”
BackgroundQi, R., Lin, E., Song, J., Wang, Y., & Lin, L. (2022) · Molecules · doi:10.3390/molecules27248784 · Cited by 22
“Cells then lose cell–cell junctions, degrade the basement membrane, and migrate out into the perivascular surroundings, which display fibroblast-like morphology and functions [112,113].”
BackgroundEguchi, T., Csizmadia, E., Kawai, H., Sheta, M., Yoshida, K., Prince, T. L., Wegiel, B., & Calderwood, S. K. (2022) · Cells · doi:10.3390/cells11243993 · Cited by 22
Namiki, T., Terakawa, J., Karakama, H., Noguchi, M., Murakami, H., Hasegawa, Y., Ohara, O., Daikoku, T., Ito, J., & Kashiwazaki, N. (2023) · Scientific Reports · doi:10.1038/s41598-023-27859-y · Cited by 22
Alsaab, H. O. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154566 · Cited by 23
Noshita, S., Kubo, Y., Kajiwara, K., Okuzaki, D., Nada, S., & Okada, M. (2023) · Journal of Cell Science · doi:10.1242/jcs.261001 · Cited by 22
Welter, L. M., Zheng, S., Setayesh, S. M., Morikado, M., Agrawal, A., Nevarez, R., Naghdloo, A., Pore, M. M., Higa, N., Kolatkar, A. R., et al. (2023) · Cancers · doi:10.3390/cancers15153949 · Cited by 22
“Under pathological conditions, cells in adult tissues rarely complete the entire EMT program, indicating that pEMT represents the norm rather than the exception [15].”
BackgroundRhinovirus induces airway remodeling: what are the physiological consequences?
Spector, C., Sanctis, C. M. D., Panettieri, R. A., & Koziol‐White, C. J. (2023) · Respiratory Research · doi:10.1186/s12931-023-02529-9 · Cited by 22
“The trans-differentiation of AECs undergoing EMT ultimately results in a shift from pseu-dostratified columnar epithelial morphology toward a mesenchymal morphology and cellular behavior that is associated with loss of epithelial barrier function [69, 71, 72].”
BackgroundYe, Z., Chen, W., Li, G., Huang, J., & Lei, J. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10147-6 · Cited by 22
“This process involves the remodeling of the tumor cell cytoskeleton and downregulation of intercellular adhesion protein expression, enabling tumor cells to penetrate the tumor capsule and endothelial cells more easily, as well as enhancing their resistance to the external environment [119, 120].”
Zhao, R., Moore, E. L., Gogol, M., Unruh, J. R., Yu, Z., Scott, A. R., Wang, Y., Rajendran, N. K., & Trainor, P. A. (2024) · eLife · doi:10.7554/elife.92844 · Cited by 23
“High levels of DLC1 expression are detected in most melanoma tissues, and functional studies have revealed that DLC1 is both necessary and sufficient for melanoma growth and metastasis ( Yang et al., 2020b ).”
Recent discovery and development of AXL inhibitors as antitumor agents
Liu, Z., Chen, L., Zhang, J., Yang, J. Y., Xiao, X., Shan, L., & Mao, W. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116475 · Cited by 22
Self-citationPerspectives in collective cell migration – moving forward
Stehbens, S. J., Scarpa, E., & White, M. D. (2024) · Journal of Cell Science · doi:10.1242/jcs.261549 · Cited by 22
Cell extrusion drives neural crest cell delamination
Moore, E. L., Zhao, R., McKinney, M. C., Yi, K., Wood, C., & Trainor, P. A. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2416566122 · Cited by 22
PRR11 and SKA2 promote the proliferation, migration and invasion of esophageal carcinoma cells
Chen, J., Yang, H., Zhou, H., Peng, R., Niu, Z., & Kang, C. (2020) · Oncology Letters · doi:10.3892/ol.2020.11615 · Cited by 22
“Snail and N-cadherin are markers of EMT, and cyclin D1 is a marker of the cell cycle (17,18).”
BackgroundGiusti, V., Ruzzi, F., Landuzzi, L., Ianzano, M. L., Laranga, R., Nironi, E., Scalambra, L., Nicoletti, G., Giovanni, C. D., Olivero, M., et al. (2021) · Oncogenesis · doi:10.1038/s41389-021-00360-9 · Cited by 22
“Moreover, we observed a transient loss of mesenchymal features in favor of epithelial traits at both the morphological and genetic levels, in sunitinib-treated cells, and this may reflect the existence of an epithelial/mesenchymal intermediate state [61].”
BackgroundYang, J., Liao, Q., Price, M., Moriarity, B. S., Wolf, N. K., Felices, M., Miller, J. S., Geller, M. A., Bendzick, L. E., Hopps, R., et al. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101318 · Cited by 22
Self-citationLugassy, C., Vermeulen, P., Ribatti, D., Pezzella, F., & Barnhill, R. L. (2022) · British Journal of Cancer · doi:10.1038/s41416-021-01686-2 · Cited by 22
E-Cadherin Signaling in Salivary Gland Development and Autoimmunity
Sisto, M., Ribatti, D., & Lisi, S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11082241 · Cited by 22
“Based on these characteristics, recently, these dynamic processes were widely defined as “epithelial–mesenchymal plasticity” [49].”
BackgroundThe short-chain fatty acid acetate modulates epithelial-to-mesenchymal transition
Lyu, J., Pirooznia, M., Li, Y., & Xiong, J. (2022) · Molecular Biology of the Cell · doi:10.1091/mbc.e22-02-0066 · Cited by 22
Wang, X., Tang, X., Li, N., Sun, Y., Yu, R., Zhang, J., Li, D., Yang, B. J., & Sun, H. (2022) · Biomaterials Science · doi:10.1039/d2bm01625g · Cited by 22
Voutsadakis, I. A. (2023) · Cancers · doi:10.3390/cancers15102689 · Cited by 22
“In adult organisms, EMT is involved in wound healing through mobilization of cells necessary for regeneration of injured tissue [22].”
BackgroundZhong, C., Wang, W., Yao, Y., Lian, S., Xie, X., Xu, J., He, S., Luo, L., Ye, Z., Zhang, J., et al. (2025) · Journal of Cancer · doi:10.7150/jca.103757 · Cited by 21
“EMT represents a key transformation where cells lose epithelial features and gain mesenchymal and stem cell-like characteristics, which enhance invasiveness [10, 11].”
McDermott, M., Mehta, R., Torres, E. T. R., & MacLean, A. L. (2025) · npj Systems Biology and Applications · doi:10.1038/s41540-025-00512-2 · Cited by 21
Kahane, N., & Kalcheim, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179141 · Cited by 21
“[63], showed the existence of a developmental checkpoint during mesoderm induction, ensuring that Sox2-expressing cells do not migrate into the mesoderm by maintaining a partial EMT state [64].”
BackgroundSelf-citationHollis, P. R., Mobley, R. J., Bhuju, J., Abell, A. N., Sutter, T. R., & Sutter, T. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179670 · Cited by 21
“Levels of CDH3 were significantly elevated by nearly 3-fold (Figure 1E) suggesting that these CYP1B1 KD cells may be in an intermediate state [19], with transition between mesenchymal and epithelial characteristics, termed epithelial-mesenchymal plasticity [20,21].”
BackgroundHypoxia as a regulator of tumor stroma and metastasis
Lee, K. E. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00158.2022 · Cited by 21
Effect of chromatin modifiers on the plasticity and immunogenicity of small-cell lung cancer
Kirk, N. A., Kim, K., & Park, K.-S. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00905-x · Cited by 21
Venkataswamy, M., Sankaran, K. R., Islam, M. S., & Meriga, B. (2023) · 3 Biotech · doi:10.1007/s13205-023-03461-x · Cited by 21
“Epithelial–mesenchymal transition (EMT) is a biological phenomenon that happens when epithelial cells acquire mesenchymal properties and is linked to numerous aspects of cancer malignancy, including metastasis, tumor invasion, and therapeutic resistance (Yang et al. 2020).”
BackgroundSuzuki, T., Conant, A., Curow, C., Alexander, A., Ioffe, Y., & Unternaehrer, J. (2023) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2023.34 · Cited by 21
“…is a reversible cellular process in which epithelial cells lose their cell-to-cell adhesion, polarity, and attachment to a basement membrane to become more motile, with mesenchymal features that include increased invasiveness, cell survival, and extracellular matrix remodeling [Figure 1A] [9] .”
BackgroundWang, W.-Y., Zhang, Y., Jian, Y., Shi, H., Liu, J., Cheng, Y., Zheng, S., Qian, Z., Gao, X., & Wang, X. (2023) · Nanoscale · doi:10.1039/d3nr05195a · Cited by 21
Self-citationCirculating Tumor Cells: From Basic to Translational Research
Cortés‐Hernández, L. E., Eslami‐S, Z., Pantel, K., & Alix‐Panabières, C. (2024) · Clinical Chemistry · doi:10.1093/clinchem/hvad142 · Cited by 21
A MAP1B–cortactin–Tks5 axis regulates TNBC invasion and tumorigenesis
Inoue, H., Kanda, T., Hayashi, G., Munenaga, R., Yoshida, M., Hasegawa, K., Miyagawa, T., Kurumada, Y., Hasegawa, J., Wada, T., et al. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202303102 · Cited by 21
“Metastasis, responsible for most cancer-related deaths, includes many complex processes, such as invasion, intravasation, extravasation, and colonization in distant tissues (Yang et al., 2020; Brabletz et al., 2021).”
Enigmatic exosomal connection in lung cancer drug resistance
Patra, S. K., Sahoo, R. K., Biswal, S., Panda, S. S., & Biswal, B. K. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102177 · Cited by 21
Anchorage Dependence and Cancer Metastasis
Lee, D. K., Oh, J., Park, H. W., & Gee, H. Y. (2024) · Journal of Korean Medical Science · doi:10.3346/jkms.2024.39.e156 · Cited by 21
EpCAM-CD24+ circulating cells associated with poor prognosis in breast cancer patients
Михайлович, П. В., Grigoryeva, E. S., Savelieva, O. E., Валерьевич, А. В., Andruhova, E. S., Zavyalova, M. V., Bragina, O., Garbukov, Е. Y., Menyailo, M. E., Khozyainova, A. A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-61516-2 · Cited by 21
“In 2020, group of researchers proposed a consensus for determining the molecular manifestations of EMT 26 .”
BackgroundGu, X., Zhou, H. F., Miao, M., Hu, D., Wang, X., Zhou, J., Teichmann, A. T., Yang, Y., & Wang, C. (2024) · PubMed Central · doi:10.2147/dddt.s464910 · Cited by 21
“158,190 Since E-cadherin has a stronger adhesive ability than N-cadherin, a decrease in E-cadherin expression and an increase in N-cadherin expression on the cell membrane surface increase cell motility and the ability to invade and metastasize.”
BackgroundResearch Progress of Fibroblasts in Human Diseases
Li, X., Li, N., Wang, Y., Han, Q., & Sun, B. (2024) · Biomolecules · doi:10.3390/biom14111478 · Cited by 21
“In the event of inflammatory injury and trauma, epithelial cells can also be transformed into Fbs and other related cell types through the EMT process, thus improving the ability of migration for tissue reconstruction [26].”
Mechanisms of breast cancer metastasis: the role of extracellular matrix
Chen, R., Zhang, R., Ke, F., Guo, X., Zeng, F., & Liu, Q. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05175-x · Cited by 21
“The transformation of epithelial cells into a mesenchymal phenotype enables them to manipulate the expression of adhesion molecules, thus enhancing their migratory and invasive capabilities [40].”
Indication of high lipid content in epithelial-mesenchymal transitions of breast tissues
Sabtu, S. N., Sani, S. F. A., Looi, L., Chiew, S.-F., Pathmanathan, D., Bradley, D. A., & Osman, Z. (2021) · Scientific Reports · doi:10.1038/s41598-021-81426-x · Cited by 21
Bhatt, A. B., Wright, T. D., Barnes, V., Chakrabarty, S., Matossian, M. D., Lexner, E., Uçar, D. A., Miele, L., Flaherty, P. T., Burow, M. E., et al. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101046 · Cited by 21
Ruan, L., Liu, W., Yang, Y., Chu, Z., Yang, C. Z., Yang, T., & Sun, J. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112735 · Cited by 21
Li, C., Hsu, T., Chang, Y., Chan, M., Lu, P., & Hsiao, M. (2021) · Biomedicines · doi:10.3390/biomedicines9091265 · Cited by 21
Bocci, F., Zhou, P., & Nie, Q. H. (2021) · Cancers · doi:10.3390/cancers13225726 · Cited by 21
“Identifying and characterizing intermediate epithelial/mesenchymal (E/M) states remains a difficult yet crucial task to advance our understanding of cancer progression [7].”
BackgroundGui, Z., Suo, C., Tao, J., Wang, Z., Zheng, M., Fei, S., Chen, H., Sun, L., Han, Z., Ju, X., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.753412 · Cited by 21
“It is divided into several subtypes, with type 2 EMT being involved in tissue regeneration, wound healing, and organ fibrosis (10).”
BackgroundPavlič, A., Hauptman, N., Boštjančič, E., & Zidar, N. (2022) · Cancers · doi:10.3390/cancers14092280 · Cited by 21
Yuan, J., Mo, Y., Zhang, Y., Zhang, Y., & Zhang, Q. (2022) · Nanotoxicology · doi:10.1080/17435390.2022.2142169 · Cited by 21
“EMT is not only found in early embryonic development to enable various morphogenetic events, but also found in cancer pathogenesis and tissue fibrosis (Yang et al. 2020).”
BackgroundShifting Shapes: The Endothelial-to-Mesenchymal Transition as a Driver for Cancer Progression
Giordanengo, L., Proment, A., Botta, V., Picca, F., Munir, H., Tao, J., Olivero, M., Taulli, R., Bersani, F., Sangiolo, D., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136353 · Cited by 20
“Epithelial–mesenchymal transition (EMT) [24–27] and EndMT [4–11] are fundamental physiological processes involved in embryonal development, cardiac morphogenesis, and wound healing.”
Harnessing Carcinoma Cell Plasticity Mediated by TGF-β Signaling
Wang, X., & Thiery, J. P. (2021) · Cancers · doi:10.3390/cancers13143397 · Cited by 20
Self-citationLi, N., Xu, X., Yang, H., Wang, H., Ouyang, Y., Zhou, Y., Peng, C., Yuan, Z., He, C., Zeng, C., et al. (2021) · Helicobacter · doi:10.1111/hel.12842 · Cited by 20
Boukhatmi, H. (2021) · Cells · doi:10.3390/cells10082112 · Cited by 20
Riva, C., Hajduskova, M., Gally, C., Suman, S. K., Ahier, A., & Jarriault, S. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111365 · Cited by 18
Pamungkas, A. S., & Halimah, N. (2023) · At-Tasyrih jurnal pendidikan dan hukum Islam · doi:10.55849/attasyrih.v7i1.150 · Cited by 20
Farina, L., Ruvio, G., Shatwan, R., Shalaby, A., O’Halloran, M., White, A., Soo, A., Breen, D. P., Lowery, A., & Quinn, A. M. (2023) · Cancers · doi:10.3390/cancers15143738 · Cited by 20
“Indeed, cells undergoing epithelial to mesenchymal transition experience a change in polarity, cytoskeleton structure and cellto-cell adhesion structure [27].”
BackgroundTransiently Increased Coordination in Gene Regulation During Cell Phenotypic Transitions
Wang, W., Ni, K., Poe, D., & Xing, J. (2024) · PRX Life · doi:10.1103/prxlife.2.043009 · Cited by 21
Self-citationNoguera, M. F., Montemurro, M., Benassayag, C., Monier, B., & Suzanne, M. (2021) · Cells and Development · doi:10.1016/j.cdev.2021.203717 · Cited by 20
Xu, S., Mo, C., Lin, J., Yan, Y., Liu, X., Wu, K., Zhang, H., Zhu, Y., Chen, L., & Chen, X. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00614-w · Cited by 20
“EMT is deemed to be a key process leading to functional changes in cell migration and invasion [18].”
BackgroundP4HA2: A link between tumor-intrinsic hypoxia, partial EMT and collective migration
Aggarwal, V., Sahoo, S., Donnenberg, V. S., Chakraborty, P., Jolly, M. K., & Sant, S. (2022) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2022.100057 · Cited by 20
Zebrafish Neuromesodermal Progenitors Undergo a Critical State Transition in vivo
Toh, K., Saunders, D., Verd, B., & Steventon, B. (2022) · iScience · doi:10.1016/j.isci.2022.105216 · Cited by 20
“This intermediate state where EMT is delayed resembles a hybrid EMT transition state found in cells with high potential for metastasis (Yang et al., 2020).”
Yang, Y., Wang, R., Ling, F., Ma, H., & Fang, J. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s282947 · Cited by 20
Long Noncoding Competing Endogenous RNA Networks in Pancreatic Cancer
Xiong, G., Pan, S., Jin, J., Wang, X., He, R., Peng, F., Xu, L., Wang, M., Zheng, J., Zhu, F., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.765216 · Cited by 20
Current Understanding of Pulmonary Fibrosis: Pathogenesis, Diagnosis, and Therapeutic Approaches
Cui, D., Che, X., An, R., Li, L., Cui, X., Jiang, L. K., & Jin, J. (2025) · Canadian Respiratory Journal · doi:10.1155/carj/3183241 · Cited by 19
Cytokeratins 5 and 17 Maintain an Aggressive Epithelial State in Basal-Like Breast Cancer
McGinn, O., Riley, D., Finlay-Schultz, J., Vinod-Paul, K., Kabos, P., & Sartorius, C. A. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0866 · Cited by 19
Janke, E. K., Chalmers, S. B., Roberts‐Thomson, S. J., & Monteith, G. R. (2023) · Cell Calcium · doi:10.1016/j.ceca.2023.102741 · Cited by 19
Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC
Šimienė, J., Dabkevičienė, D., Stančiūtė, D., Prokarenkaitė, R., Jablonskienė, V., Aškinis, R., Normantaite, K., Cicėnas, S., & Sužiedėlis, K. (2023) · BMC Cancer · doi:10.1186/s12885-023-11365-5 · Cited by 19
“Study results demonstrate, that EMT is an essential process for tumor cells to receive invasive and metastatic potential [35], therefore miR-181a-5p, despite its gender-associated expression is very likely to have potential as a diagnostic and prognostic biomarker in lung cancer.”
BackgroundPiperlongumine: the amazing amide alkaloid from Piper in the treatment of breast cancer
Mitra, S., Biswas, P., Bandyopadhyay, A., Gadekar, V. S., Gopalakrishnan, A. V., Kumar, M., Radha, & Nandy, S. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02673-5 · Cited by 19
“These cells can leave the sites of primary tumours, travel to other tissues, and form novel tumours that are more genetically and phenotypically heterogeneous compared to the original tumour (Yang et al. 2020).”
Zhang, J., Xie, W., Ni, B., Li, Z., Feng, D., Zhang, Y., Han, Q., Zhou, H., Gu, M., & Tan, R. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2023.107051 · Cited by 19
Brand, J., Haro, M., Lin, X., Rimel, B. J., McGregor, S. M., Lawrenson, K., & Dinh, H. Q. (2024) · iScience · doi:10.1016/j.isci.2024.108990 · Cited by 19
San, S. H., & Ngai, S. C. (2024) · Gene · doi:10.1016/j.gene.2024.148293 · Cited by 19
Chen, Z., Lu, P., Li, M., Zhang, Q., He, T., & Gan, L. (2024) · Medicine · doi:10.1097/md.0000000000037264 · Cited by 19
“[35] In exploring cancer biology, understanding the interaction between the PI3K-Akt-mTOR signaling pathway and EMT is of significant importance.”
BackgroundRazavi-Mohseni, M., Huang, W., Guo, Y. A., Shigaki, D., Ho, S. W. T., Tan, P. B. O., Skanderup, A. J., & Beer, M. (2024) · Genome Research · doi:10.1101/gr.278565.123 · Cited by 19
“EMT in cancer is a complex process (Yang et al. 2020; Lovisa 2021), but we found that individual GC cell lines activate the gene expression signature associated with EMT to varying degrees.”
Li, S., Zhang, N., Zhang, H., Wang, N., Du, Y.-Y., Li, H.-N., Huang, C., & Li, X. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216995 · Cited by 19
Wu, Z., Ke, Q., Jiang, L., Hong, H., Pan, W. D., Chen, W., Abudukeremu, X., She, F., & Chen, Y. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06800-9 · Cited by 19
da Silva, P. B., Zhao, X., Bidarra, S. J., Nascimento, D. S., LaLone, V., Lourenço, B. N., Paredes, J., Stevens, M. M., & Barrias, C. C. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401032 · Cited by 19
Characterization of EpCAM-Positive and EpCAM-Negative Tumor Cells in Early-Stage Breast Cancer
Михайлович, П. В., Grigoryeva, E. S., Валерьевич, А. В., Kalinchuk, A. V., Сергеевна, А. Е., Savelieva, O. E., Patskan, I. A., Bragina, O., Garbukov, Е. Y., Александровна, В. М., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011109 · Cited by 19
Metadata
- Authors
- Yang, J., Antin, P., Berx, G., Blanpain, C., Brabletz, T., Bronner, M., Campbell, K., Cano, A., Casanova, J., Christofori, G., Dedhar, S., Derynck, R., Ford, H. L., Fuxe, J., García de Herreros, A., Goodall, G. J., Hadjantonakis, A.-K., Huang, R. Y. J., Kalcheim, C., Kalluri, R., Kang, Y., Khew-Goodall, Y., Levine, H., Liu, J., Longmore, G. D., Mani, S. A., Massagué, J., Mayor, R., McClay, D., Mostov, K. E., Newgreen, D. F., Nieto, M. A., Puisieux, A., Runyan, R., Savagner, P., Stanger, B., Stemmler, M. P., Takahashi, Y., Takeichi, M., Theveneau, E., Thiery, J. P., Thompson, E. W., Weinberg, R. A., Williams, E. D., Xing, J., Zhou, B. P., Sheng, G., & On behalf of the EMT International Association (TEMTIA)
- Affiliations
- University of California San Diego (US)
- University of Arizona (US)
- Ghent University (BE)
- Université Libre de Bruxelles (BE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Sheffield (GB)
- Instituto de Investigaciones Biomédicas Sols-Morreale (ES)
- Consejo Superior de Investigaciones Científicas (ES)
- University of Basel (CH)
- University of British Columbia (CA)
- University of California, San Francisco (US)
- University of Colorado Anschutz (US)
- Karolinska University Hospital (SE)
- South Australia Pathology (AU)
- Memorial Sloan Kettering Cancer Center (US)
- National Taiwan University (TW)
- Hebrew University of Jerusalem (IL)
- The University of Texas MD Anderson Cancer Center (US)
- Princeton University (US)
- Northeastern University (US)
- Washington University in St. Louis (US)
- University College London (GB)
- Duke University (US)
- Royal Children's Hospital (AU)
- Instituto de Neurociencias (ES)
- Lyon 1 Université (FR)
- Inserm (FR)
- University of Pennsylvania (US)
- Kyoto University (JP)
- RIKEN Center for Biosystems Dynamics Research (JP)
- Guangzhou Regenerative Medicine and Health Guangdong Laboratory (CN)
- Translational Research Institute (AU)
- Whitehead Institute for Biomedical Research (US)
- Queensland University of Technology (AU)
- University of Pittsburgh (US)
- University of Kentucky (US)
- International Research Center for Medical Sciences, Kumamoto University (JP)
- Corresponding author
- Yang, Jing
- Sheng, Guojun
- ORCID
- Yang, Jing
- Antin, Parker
- Berx, Geert
- Blanpain, Cédric
- Brabletz, Thomas
- Campbell, Kyra
- Casanova, Jordi
- Christofori, Gerhard
- Dedhar, Shoukat
- Derynck, Rik
- Ford, Heide L.
- Fuxe, Jonas
- Goodall, Gregory J.
- Hadjantonakis, Anna-Katerina
- Huang, Ruby Y. J.
- Kalcheim, Chaya
- Kalluri, Raghu
- Kang, Yibin
- Levine, Herbert
- Liu, Jinsong
- Longmore, Gregory D.
- Mani, Sendurai A.
- Massagué, Joan
- Mayor, Roberto
- McClay, David
- Mostov, Keith E.
- Newgreen, Donald F.
- Nieto, M. Angela
- Puisieux, Alain
- Runyan, Raymond
- Savagner, Pierre
- Stanger, Ben
- Stemmler, Marc P.
- Takahashi, Yoshiko
- Takeichi, Masatoshi
- Theveneau, Eric
- Thiery, Jean Paul
- Thompson, Erik W.
- Weinberg, Robert A.
- Williams, Elizabeth D.
- Xing, Jianhua
- Zhou, Binhua P.
- Sheng, Guojun
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2020-04-16
- Volume
- 21
- Issue
- 6
- Pages
- 341-352
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- PMC
- PMC7250738
- OpenAlex
- W3016840787
- Cited by
- 2,226
- References
- 139
- Citations by year
- 2026: 249 · 2025: 382 · 2024: 403 · 2023: 396 · 2022: 386 · 2021: 313 · 2020: 88
- FWCI
- 32.46
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-10-15)
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
- QUT ePrints (Queensland University of Technology) (submittedVersion, cc-by)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, cc-by)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Biblos-e Archivo (Universidad Autónoma de Madrid) (submittedVersion, public-domain)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion, cc-by)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- Hispana (submittedVersion)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (204615/Z/16/Z)
- Biotechnology and Biological Sciences Research Council (BB/R00627X/1, BB/T013044/1)
- Japan Society for the Promotion of Science (19H04775, 20K21425, 18H02452, 20K20520, 16KT0071)
- National Cancer Institute (R01CA223758, R37CA232209, P30CA023100, P30CA016672)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK119232)
- National Institute of Environmental Health Sciences (P30ES006694)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P41HD088362)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- epithelial-mesenchymal transition, nomenclature, research guidelines, cell migration, cell invasion, transcription factors, cancer, developmental processes
- MeSH terms
- Cell Plasticity, Animals, Cell Movement, Humans, Neoplasms, Terminology as Topic, Developmental Biology, Consensus, Biomedical Research, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.